Farb N

Psychedelic Studies Research Program, University of Toronto, Mississauga, Ontario, Canada.

3 papers · 1 preprint

ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.

Beidas Z, Ragnhildstveit A, Blackman A +8

Europe PMC2026
PreprintPsilocybin

Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial

Petranker R, Farb N, Syed O +4

Europe PMC2026
ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.

Beidas Z, Ragnhildstveit A, Blackman A +9

Europe PMC2026
ArticlePsilocybin

Psychedelic Research and the Need for Transparency: Polishing Alice's Looking Glass.

Petranker R, Anderson T, Farb N

Europe PMC2020